These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 32522677)

  • 1. Congenital heart disease with pulmonary artery hypertension in an Asian cohort-initial report from TACHYON (TAiwan congenital heart disease associated with pulmonarY arterial hypertension) registry.
    Chiu SN; Weng KP; Lin MC; Wang JN; Hwang BT; Dai ZK; Lin SM; Chang JS; Lin IC; Wu MH; Lu CW; Lin MT; Chen CA; Hua YC; Wu JM; Wang JK;
    Int J Cardiol; 2020 Oct; 317():49-55. PubMed ID: 32522677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 3. Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry.
    Xie F; Quan R; Zhang G; Tian H; Chen Y; Yu Z; Zhang C; Liu Y; Zhu X; Wu W; Zhu X; Yang Z; Gu Q; Xiong C; Han H; Cheng Y; He J; Wu Y
    J Heart Lung Transplant; 2023 Jul; 42(7):974-984. PubMed ID: 37002152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
    Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The COngenital HeARt Disease in adult and Pulmonary Hypertension (COHARD-PH) registry: a descriptive study from single-center hospital registry of adult congenital heart disease and pulmonary hypertension in Indonesia.
    Dinarti LK; Hartopo AB; Kusuma AD; Satwiko MG; Hadwiono MR; Pradana AD; Anggrahini DW
    BMC Cardiovasc Disord; 2020 Apr; 20(1):163. PubMed ID: 32264836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry.
    Duffels MG; Engelfriet PM; Berger RM; van Loon RL; Hoendermis E; Vriend JW; van der Velde ET; Bresser P; Mulder BJ
    Int J Cardiol; 2007 Aug; 120(2):198-204. PubMed ID: 17182132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].
    Kaemmerer H; Gorenflo M; Hoeper M; Huscher D; Ewert P; Pittrow D
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1247-52. PubMed ID: 23720182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guideline implementation and early risk assessment in pulmonary arterial hypertension associated with congenital heart disease: A retrospective cohort study.
    Deng X; Jin B; Li S; Li Y; Zhou H; Wu Y; Yan M; Hu Y; Qiu Q; Zhang G; Zheng X
    Clin Respir J; 2019 Nov; 13(11):693-699. PubMed ID: 31419027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China: Insights From a National Multicenter Prospective Registry.
    Qian Y; Quan R; Chen X; Gu Q; Xiong C; Han H; Zhang G; Chen Y; Yu Z; Tian H; Liu Y; Zhu X; Li S; Zhang C; He J
    Chest; 2023 Jun; 163(6):1531-1542. PubMed ID: 36470418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry.
    Chazova IE; Arkhipova OA; Martynyuk TV
    Ter Arkh; 2019 Mar; 91(1):24-31. PubMed ID: 31090367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension and congenital heart disease: An insight from the REHAP National Registry.
    Alonso-Gonzalez R; Lopez-Guarch CJ; Subirana-Domenech MT; Ruíz JMO; González IO; Cubero JS; Del Cerro MJ; Salvador ML; Subira LD; Gallego P; Escribano-Subias P;
    Int J Cardiol; 2015 Apr; 184():717-723. PubMed ID: 25781723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New predictors of mortality in adults with congenital heart disease and pulmonary hypertension: Midterm outcome of a prospective study.
    Schuuring MJ; van Riel AC; Vis JC; Duffels MG; van Dijk AP; de Bruin-Bon RH; Zwinderman AH; Mulder BJ; Bouma BJ
    Int J Cardiol; 2015 Feb; 181():270-6. PubMed ID: 25535690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
    D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
    Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Assessment Tool Implementation in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension.
    Yaylalı YT; Yağmur B; Sinan ÜY; Meriç M; Başarıcı İ; Kılıçkıran Avcı B; Şenol H; Nalbantgil S; Küçükoğlu S; Öngen Z
    Anatol J Cardiol; 2023 Aug; 27(8):479-485. PubMed ID: 37288853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital heart disease-associated pulmonary arterial hypertension: preliminary results from a novel registry.
    Rose ML; Strange G; King I; Arnup S; Vidmar S; O'Donnell C; Kermeen F; Grigg L; Weintraub RG; Celermajer DS
    Intern Med J; 2012 Aug; 42(8):874-9. PubMed ID: 22212153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment goals of pulmonary hypertension.
    McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension.
    Daly CM; Griffiths M; Simpson CE; Yang J; Damico RL; Vaidya RD; Williams M; Brandal S; Jone PN; Polsen C; Ivy DD; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Nies MK; Rosenzweig EB; Hirsch R; Yung D; Everett AD
    J Am Heart Assoc; 2021 Oct; 10(20):e021409. PubMed ID: 34622662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening study of pulmonary arterial hypertension in patients with congenital heart diseases].
    Sun YJ; Pang KJ; Zeng WJ; Wang H; He JG
    Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1091-4. PubMed ID: 22781765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease.
    Luna-Lopez R; Segura de la Cal T; Sarnago Cebada F; Martin de Miguel I; Hinojosa W; Cruz-Utrilla A; Velazquez MT; Delgado JF; Mendoza A; Arribas Ynsaurriaga F; Escribano-Subías P
    Heart; 2024 Feb; 110(5):346-352. PubMed ID: 37903556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines.
    Dardi F; Manes A; Guarino D; Zuffa E; De Lorenzis A; Magnani I; Rotunno M; Ballerini A; Lo Russo GV; Nardi E; Galiè N; Palazzini M
    Open Heart; 2021 Oct; 8(2):. PubMed ID: 34667092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.